2. Academic Validation
  3. Tumor-intrinsic P2RY6 drives immunosuppression by enhancing PGE2 production

Tumor-intrinsic P2RY6 drives immunosuppression by enhancing PGE2 production

  • Cell Rep. 2024 Jul 23;43(7):114469. doi: 10.1016/j.celrep.2024.114469.
Xilong Xu 1,  Yi Lu 2,  Longzhi Cao 3,  Yang Miao 4,  Yamei Li 3,  Yue Cui 1,  Ting Han 5
Affiliations

Affiliations

  • 1 College of Life Sciences, Beijing Normal University, Beijing 100875, China; National Institute of Biological Sciences, Beijing 102206, China.
  • 2 National Institute of Biological Sciences, Beijing 102206, China; Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 102206, China.
  • 3 National Institute of Biological Sciences, Beijing 102206, China; Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
  • 4 National Institute of Biological Sciences, Beijing 102206, China; PTN Joint Graduate Program, School of Life Sciences, Tsinghua University, Beijing 100084, China.
  • 5 College of Life Sciences, Beijing Normal University, Beijing 100875, China; National Institute of Biological Sciences, Beijing 102206, China; Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 102206, China. Electronic address: hanting@nibs.ac.cn.
PMID: 38996067 DOI: 10.1016/j.celrep.2024.114469
Abstract

Despite the success of anti-programmed cell death-1 (anti-PD-1) immunotherapy, many Cancer patients remain unresponsive, and reliable predictive biomarkers are lacking. Here, we show that aberrant expression of the pyrimidinergic receptor P2RY6 is frequent in human cancers and causes immune evasion. In mouse syngeneic and human xenograft tumor models, ectopic expression of P2RY6 shapes an immunosuppressive tumor microenvironment (TME) to enhance tumor growth and resistance to immunotherapy, whereas deletion of P2RY6 from tumors with high P2RY6 expression inflames the TME to inhibit tumor growth. As a G protein-coupled receptor, P2RY6 activates Gq/Phospholipase C-β signaling and stimulates the synthesis of prostaglandin E2, which is a key mediator of immunosuppression in the TME. In contrast to the essential role of P2RY6 in tumors, global deletion of P2ry6 from mice does not compromise viability. Our study thus nominates P2RY6 as a precision immunotherapy target for patients with high tumor-intrinsic P2RY6 expression.

Keywords

CP: Cancer; CP: Immunology; P2RY6; immunotherapy resistance; prostaglandin E2; tumor microenvironment; tumor immune evasion.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z